Breakingviews: Valeant effort

The embattled $40 bln pharmaceuticals company tried – but failed – to quell concerns about its convoluted dealings with distributors. Rob Cyran and Jeffrey Goldfarb discuss why.

from Reuters Video: Breakingviews http://ift.tt/1LXumvX
via IFTTT